Identification of the genetic loci underlying asthma in humans has been hampered by variability in clinical phenotype, uncontrolled environmental influences, and genetic heterogeneity. To circumvent these complications, the genetic regulation of asthma-associated phenotypes was studied in a murine model. We characterized the strain distribution patterns for the asthma-related phenotypes airway hyperresponsiveness (AHR), lung eosinophils, and ovalbumin (OVA)-specific serum immunoglobulin (Ig) E induced by allergen exposure protocols in A/J, AKR/J, BALB/cJ, C3H/HeJ, and C57BL/6J inbred strains and in (C3H/HeJ ϫ A/J)F1 mice. Expression of AHR differed between strains and was sometimes discordant with lung eosinophils or serum IgE. Furthermore, we identified two distinct quantitative trait loci (QTL) for susceptibility to allergeninduced AHR, Abhr1 (allergen-induced bronchial hyperresponsiveness) (lod ϭ 4.2) and Abhr2 (lod ϭ 3.7), on chromosome 2 in backcross progeny from A/J and C3H/HeJ mice. In addition, a QTL on chromosome 7 was suggestive of linkage to this trait. These QTL differ from those we have previously found to control noninflammatory AHR in the same crosses. Elucidation of the genes underlying these QTL will facilitate the identification of biochemical pathways regulating AHR in animal models of asthma and may provide insights into the pathogenesis of human disease.
Asthma is a chronic, often debilitating disease that afflicts more than 15 million people in the United States alone (1) . The cardinal features of allergic asthma are airway hyperresponsiveness (AHR) to a variety of stimuli, pulmonary eosinophilia, and elevated serum immunoglobulin (Ig) E levels. It is generally accepted that asthma is an inflammatory disorder arising as a result of inappropriate immune responses to common environmental antigens in genetically susceptible individuals. However, the mechanisms underlying susceptibility to such aberrant immune responses are not known. A mechanistic understanding of the pathogenesis of allergic asthma should facilitate the development of novel therapeutics for this increasingly prevalent disease.
Genetic analyses can enhance our understanding of the molecular mechanisms of asthma. Family and twin studies have demonstrated a heritable predisposition to asthma and phenotypic markers of asthma, such as AHR and elevated serum IgE levels (2, 3) . Despite this, identification of genetic susceptibility loci has been difficult. The genetic mapping of asthma susceptibility has yielded evidence for several quantitative trait loci (QTL) (4-7) but has been hampered by factors including variability in clinical phenotype, uncontrolled environmental influences, and genetic heterogeneity underlying asthma in human populations. Inbred murine models of allergic asthma provide an attractive pathway through these complexities. Advantages of murine models include genetic homogeneity within inbred populations, controlled breeding, environmental homogeneity, and the ability to apply a uniform allergic stimulus to the population. Previously, Ewart and coworkers (8) and De Sanctis and colleagues (9, 10) identified multiple QTL linked to noninflammatory AHR in specific inbred mouse strains. More recently, Zhang and associates (11) reported QTL on different chromosomal regions for allergen-induced AHR in crosses from Biozzi BP2 and BALB/c mouse strains. To further investigate the genetic mechanisms of asthma-related phenotypes associated with allergen exposure, we examined strain distribution patterns for the asthma-related phenotypes AHR, bronchoalveolar lavage (BAL) eosinophil counts, and serum IgE in five inbred mouse strains after allergen sensitization and challenge. We subsequently examined the genetic regulation of allergen-induced AHR in backcross offspring from A/J and C3H/HeJ mice, the two inbred strains with greatest differential expression of this trait. Two distinct QTL for allergen-induced AHR were identified on chromosome 2, and suggestive evidence of an additional QTL for this trait was noted on chromosome 7.
Materials and Methods

Animals
Studies were performed in age-matched, virus-free, male mice obtained from Jackson Laboratory (Bar Harbor, ME) at 4 wk of age and allowed to acclimate for 1 to 2 wk before experimentation. A/J ( n ϭ 94), AKR/J ( n ϭ 5), BALB/cJ ( n ϭ 5), C57BL/6J ( n ϭ 7), C3H/HeJ ( n ϭ 99), (C3H/HeJ ϫ A/J)F1 ( n ϭ 39), (A/J ϫ C3H/ HeJ)F1 ( n ϭ 
Measuring Allergen-Induced Phenotypes
We measured indices of allergic inflammation and airway responsiveness in inbred strains of mice and in various inbred strainderived crosses. On Day 0, mice were sensitized intraperitoneally with 10 g chicken egg OVA (crude grade IV; Sigma, St. Louis, MO) in 0.2 ml calcium and magnesium-free phosphate-buffered saline (PBS) or an equivalent amount of PBS alone. On Day 14 mice were anesthetized (ketamine, 45 mg/kg, intraperitoneally and xylazine, 8 mg/kg, intraperitoneally), challenged with an aspiration of 1.5% OVA in 50 l PBS or PBS alone, and recovered from anesthesia. On Day 17, airway responsiveness, BAL eosinophil counts, and serum IgE phenotypes were assessed. Airway responsiveness to intravenous acetylcholine (50 g/kg) challenge was assessed as previously described (12) , with minor modifications (13, 14) , and reported as the airway pressure time index (APTI), which assesses time-integrated changes in peak inspiratory pressure. Immediately after AHR measurements, lungs were lavaged with one 0.1-ml aliquot of Hanks' buffered saline solution (HBSS). The lavage fluid was centrifuged at 300 ϫ g for 10 min, the cell pellet was resuspended in 1 ml HBSS, and cells were counted with a hemocytometer. Slide preparations were stained with Diff-Quik (Baxter, McGraw Park, IL), and BAL cell differential percentages were determined based on light microscopic evaluation of at least 500 cells per slide.
Sera were obtained from blood taken during exsanguination of the mice after airway measurements. OVA-specific IgE levels were determined by enzyme-linked immunosorbent assay. Sample wells were coated with a 0.01% OVA solution in PBS, blocked with 10% fetal bovine serum (FBS) in PBS, and washed with 0.05% Tween-20 in PBS. Serum sample were diluted 1:10 with 10% FBS in PBS. After an overnight incubation, plates were washed with 0.05% Tween-20 in PBS, and biotin-conjugated antimouse IgE (PharMingen, San Diego, CA) was added. After a wash, avidin peroxidase (0.0025 mg/ml) in 10% FBS/PBS was added, and plates were developed with 2,2 Ј -azino-di(3-ethyl-benzthiazone sulfonate) (Kirkegaard and Perry, Gaithersburg, MD). Plates were read at 405 nm within 30 min. Data are reported as optical density readings.
Genotyping
Genotypes were determined for A/J backcross mice at multiple DNA markers for subsequent linkage analysis. Genomic DNA was extracted from kidneys as previously described (8) . Microsatellite DNA markers ( n ϭ 164), spaced at approximately 10-centimorgan (cM) intervals throughout the genome, that varied between A/J and C3H/HeJ mice were studied using primer pairs obtained from Research Genetics (Huntsville, AL). DNA samples were amplified by polymerase chain reaction (PCR) (15) and analyzed by gel electrophoresis (15) . Amplification conditions were optimized for each marker based on primer composition. If the base pair difference between the A/J and C3H/HeJ strains was less than 10, one primer was radiolabeled and the PCR products were separated on acrylamide gels and viewed by autoradiography. PCR products with larger base pair differences were separated on agarose gels, stained with ethidium bromide, and viewed under ultraviolet illumination.
To 
Linkage Analysis
QTL mapping was performed to detect loci contributing to the allergen-induced AHR phenotype. Map orders and distances were established with our genotype data using MAPMAKER/EXP, and interval mapping using the complete phenotype dataset was then performed by MAPMAKER/QTL (16) . Lod scores were calculated at 1-cM intervals throughout the genome. A lod of 1.9 was the threshold for suggestive evidence of linkage, and a lod у 3.3 was interpreted as significant evidence of linkage (17) . Where evidence of linkage was found on the genome screen, additional A/J backcross mice and markers were tested to support and refine the initial linkages.
Composite Interval Mapping and Resampling Methods
Standard interval mapping methods identified two adjacent lod score peaks on chromosome 2 (intervals of interest defined by markers D2Mit359 to D2Mit416 and D2Mit238 to D2Mit298 ). Therefore, additional analyses were performed to determine whether these adjacent peaks defined two separate QTL or a single locus with a broad linkage. Composite interval mapping enhances the ability to detect linked QTL over standard interval mapping approaches by incorporating markers as cofactors linked to the interval of interest into the statistical model for marker-trait association (18) . Explicitly including these cofactors into the model serves to control for genetic background effects that would otherwise be confounded with the experimental error terms, which, in turn, reduce the chances of detecting linked QTL. We found that the choice of markers used as cofactors in the composite interval mapping analysis yielded significantly different results regarding the level of support for two QTL on chromosome 2. Due to the variations realized in selecting different cofactors for the composite interval mapping technique, we also employed the conditional empirical threshold method developed by Doerge and Churchill (19) . The conditional empirical threshold method is a nonparametric resampling method (permutation test) that classifies samples according to the genotype of the marker with the greatest marker-trait association. This process serves to control for the effects of the QTL with the greatest marker-trait association. The trait data within each class are then permuted and these permuted data are then analyzed by computing a test statistic ( t test statistic in our case) over markers outside the linkage group containing the conditioned marker. The permutation and analysis steps are repeated a large number of times, which results in the estimation of a critical value for each marker at a prespecified significance level used to determine whether that marker is significantly associated with the trait. If markertrait associations exceed the critical value set by the permutation test, the association is deemed significant. The power of this approach is that it makes no distribution assumptions about the trait values or the additive/nonadditive effects of the QTL linked to the marker with the greatest marker-trait association (19) .
To better resolve the peaks detected on chromosome 2, the markers included as cofactors were chosen using a forward-backward stepwise regression procedure that identified those markers with the largest effect on the quantitative trait (20) . Inclusion of markers that were not linked with the chromosome 2 interval of interest resulted in no significant changes to the lod score curve on chromosome 2. Single marker t tests were then applied to each chromosome 2 marker to identify those markers outside of the two intervals of interest with the largest effect on the quantitative trait. Because the markers used in this analysis were so closely spaced in the chromosome 2 intervals of interest, the single marker t test was used as it provides a more powerful means to detect linkage when compared with standard interval mapping approaches (21) . We validated the results of the single marker t tests by establishing empirical threshold values for each marker using the permutation test by Churchill and Doerge (22) . The markers with significant P values from the t test exceeded the empirical threshold of significance established by the permutation test, and so the results of the two tests yielded equivalent results. The most significant markers flanking the two intervals of interest were then used as cofactors, as well as all markers between the two intervals, in the composite interval mapping method implemented by Basten and colleagues (23) .
Results
Strain Distribution Patterns of Allergen-Induced Phenotypes
We previously demonstrated that A/J and C3H/HeJ mice have significantly different airway responsiveness to cholinergic agonists under noninflammatory conditions (8) together with markedly different airway responsiveness to such agonists after allergen sensitization (13, 14) . We and others have shown that noninflammatory airway responsiveness is under genetic control (8) (9) (10) 12) . However, the relationship, if any, of noninflammatory AHR to the propensity to develop allergen-induced AHR was unknown. To select strains suitable for investigating the genetic basis of allergic asthma, we characterized strain distribution patterns for asthma-related phenotypes in five inbred strains after PBS or OVA sensitization and challenge. After allergen immunization and airway challenge, striking increases in AHR were observed in A/J and AKR/J mice, relative to their antigenically naive (PBS-challenged) littermate controls ( Figure 1A ). In contrast, allergen challenge did not induce significant changes in airway responsiveness in C57BL/6J and C3H/HeJ mice. OVA induced an increase above PBS control levels in the BALB/cJ strain; however, OVA-induced AHR in BALB/cJ mice was intermediate as compared with the hyperresponsive A/J and AKR strains and the hyporesponsive C57BL/6J and C3H/HeJ strains. Allergen exposure induced a marked increase in eosinophil numbers in the BAL of A/J mice as well as significant, but less dramatic, increases in BAL eosinophils in C3H/ HeJ and BALB/cJ strains ( Figure 1B) . No significant increases in eosinophil numbers were detected in AKR/J or C57BL/6J mice. OVA-specific serum IgE was not detected in serum samples from any mouse strain after sham sensitization with PBS as might be expected. Allergen exposure significantly increased the production of OVA-specific IgE in A/J mice ( Figure 1C) . No statistically significant increases in IgE levels were observed in other mouse strains after allergen exposure.
Of the strains studied, A/J mice were maximally responsive in terms of induction of AHR, eosinophil infiltration, and elevated serum IgE after allergen exposure. C3H/HeJ and C57BL/6J mice were minimally responsive to allergen exposure as assessed by AHR and serum IgE, but C3H/HeJ mice did demonstrate induction of BAL eosinophilia after allergen exposure. Because we have extensively characterized the airway and inflammatory responses of C3H/HeJ mice in previous studies (13, 24) and we were interested in comparing the previously determined map location for noninflammatory AHR (determined in C3H/HeJ ϫ A/J crosses) (8) with QTL positions for allergen-induced AHR, we selected the low respond- Figure 1 . Comparison of three asthma-related phenotypes in A/J, AKR/J, BALB/cJ, C57BL/6J, and C3H/HeJ mice. Mice were sensitized and intratracheally challenged with either PBS or OVA, and the phenotypes were assessed 3 d after PBS (open bars) or OVA (solid bars) challenge. (A) AHR to acetylcholine challenge was determined by measurement of the time-integrated rise in peak inspiratory pressure (APTI in cm H 2 O ؒ s); (B) the absolute number of eosinophils in BAL fluids; and (C) OVA-specific serum IgE levels. IgE was undetectable in PBS-treated mice of all strains and in C57BL/6J mice after OVA exposure. The results are means Ϯ SEM of five to 10 animals per group. *P Ͻ 0.05 compared with the PBS control for each strain (one-way ANOVA followed by Fisher's least significant difference test for multiple comparisons).
† P Ͻ 0.05 compared with OVA-challenged A/J mice.
ing C3H/HeJ strain together with the hyperresponsive A/J strain for further genetic analysis.
Expression Patterns of Allergen-Induced Airway Phenotypes
To gain further insight into the inheritance of allergeninduced AHR, BAL eosinophil counts, and OVA-specific serum IgE, these traits were determined in a subset of (C3H/HeJ ϫ A/J)F1 mice ( Figure 2 ). Noninflammatory AHR values in the F1 mice were similar to values in the A/J parental strain. In contrast, the AHR response after allergen exposure in the F1 mice mimicked the C3H/HeJ strain as no further increase in AHR above noninflammatory levels was seen. Eosinophil and IgE values in F1 mice were increased by allergen exposure and tended to be intermediate to the parental strains. Furthermore, whereas eosinophils were induced by OVA exposure in both the parental strains and the F1, OVA-induced IgE increases were seen in A/J and F1 mice but not in the C3H/HeJ progenitor strain.
Because we were interested in comparing the genetic basis of noninflammatory AHR with that of allergen-induced AHR, we chose to focus the subsequent linkage studies on 
QTL Mapping
Linkage analysis was performed on A/J backcross mice in order to investigate the chromosomal location of QTL contributing to allergen-induced AHR. The genome screen revealed several linkages. Two lod score peaks for allergen-induced AHR were indicated near the centromere on chromosome 2 ( Figure 4) ; a lod score of 4.2 was obtained between markers D2Mit359 and D2Mit416, and a lod score of 3.7 was obtained between markers D2Mit238 and D2Mit298 (Table 1) . It was important to determine whether the two lod score peaks on chromosome 2 contained a single QTL or two linked loci; thus, composite interval mapping and the conditional empirical threshold method were performed. Lod scores obtained by composite interval mapping were 4.2 for the interval spanning D2Mit359 to D2Mit416, 3.7 for the interval spanning D2Mit238 to D2Mit298, and approached zero between these regions ( Figure 4 ). This indicated that the cofactors analyzed were able to account for a significant portion of the genetic background in this region but not in the two intervals of interest. These results were obtained by allowing markers D2M359, D2M416, D2M465, D2M81, D2M238, and D2M298 to serve as cofactors. Interestingly enough, markers D2M465 and D2M81 were driven sharply toward zero when markers flanking the two peaks were used as cofactors; however, the reduction was not as dramatic when markers D2Mit82 and D2Mit152 were pulled into the composite interval mapping analysis. To further test whether the two lod score peaks represented two linked loci, the conditional empirical threshold method was applied to the data by conditioning on the marker with the greatest marker-trait association, D2Mit416. None of the conditional empirical thresholds determined by markers between D2Mit416 and D2M298 at the 0.05 significance level were exceeded by these markers. However, the experimentwise 95% critical value for declaring a second QTL was 3.96 for marker D2Mit298, which had a t test statistic of 3.90 (empirically derived P value equal to 0.06), just below the 0.05 threshold for significance. While not as striking as the composite interval mapping result, the results of the conditional empirical threshold method offered support for the two loci hypothesis. The results of the composite interval mapping and conditional empirical threshold analyses indicated that two distinct QTL gave the most parsimonious explanation for the linkage. Thus, the QTL that mapped in the interval between D2Mit359 and D2Mit416 was termed Abhr1 (allergen-induced bronchial hyperresponsiveness), while the nearby QTL defined by D2Mit238 and D2Mit298 was termed Abhr2. Suggestive evidence of linkage was also found on chromosome 7 with a maximum lod ϭ 1.9 obtained in the interval between Figure 4 . Lod score curves for interval mapping and composite interval map analysis on chromosome 2 for allergen-induced AHR in A/J backcross mice. Interval mapping (solid line) indicated two lod score peaks spanning D2Mit359 to D2Mit416 (peak lod ϭ 4.2) and D2Mit238 to D2Mit298 (peak lod ϭ 3.7). Composite interval mapping analysis (dashed line) and conditional empirical threshold methods resolved these adjacent lod score peaks into two distinct QTL termed Abhr1 and Abhr2. Markers with lod scores greater than 1.9 were successfully genotyped in an average of 163 phenotypically extreme A/J backcross mice. Other markers were tested in an average of 84 A/J backcross mice in the tails of the phenotypic distribution. D7Mit21 and D7Mit56 (Table 1) . Together, the loci on chromosomes 2 and 7 were calculated to explain 23% of the variance in allergen-induced AHR between A/J and C3H/HeJ mice. Analysis of variance (ANOVA) methods, including all cross-terms for two-way and three-way interactions, were applied to determine if there were significant genetic interactions between Abhr1, Abhr2, and the QTL on chromosome 7. Neither Abhr1 nor Abhr2 had a detectable interaction with the QTL on chromosome 7 (P Ͼ 0.05). Although the interaction between Abhr1 and Abhr2 was statistically significant (P Х 0.01), the result should be approached with caution because the statistic used to assess significance in the two-way ANOVA model assumes the data are normally distributed, and we detected significant departures from normality in these data. However, the statistical tests used for ANOVA models are generally robust to departures from normality, so we can have confidence the interaction between the loci is present, but the level of significance cannot be precisely determined.
Discussion
Human asthma encompasses allergy, inflammation, and AHR; the model we used in the current studies contains these features as well. To select strains suitable for investigating the genetic basis of allergic asthma, we characterized strain distribution patterns for asthma-related phenotypes in five inbred strains after sham or allergen sensitization and challenge. We show that immunization and subsequent challenge with allergens induces in certain strains of mice a phenotype very similar to that observed in human asthma. The level of allergen-induced AHR varied significantly in the five strains studied. Furthermore, we found variation between strain distribution patterns for allergen-induced AHR as compared with BAL eosinophils or serum IgE, suggesting different genetic mechanisms underlying these traits. Additionally, we found significant evidence for two newly described and distinct QTL on chromosome 2, Abhr1 and Abhr2, that contribute to the allergen-induced AHR phenotype. Suggestive evidence was also found of a QTL for allergen-induced AHR on chromosome 7. Thus, our results provide evidence of unique QTL contributing to an important asthma-related phenotype and yield insight into the relationships between allergen-induced AHR, BAL eosinophils, and serum IgE.
Our results of discordant strain distribution patterns for allergen-induced AHR, as compared with BAL eosinophils or serum IgE, provide evidence that allergen-induced AHR is regulated by different genetic mechanisms than the eosinophil or IgE phenotypes. Although the A/J strain had the highest values for all phenotypes examined and the C57BL/6J strain was the most consistently unresponsive, phenotype-specific variation was noted in the other strains. The most dramatic example was in the AKR/J strain, which demonstrated extreme airway responsiveness and yet had minimal induction of airway eosinophils or serum IgE after allergen exposure. This phenotype discordance is consistent with our previous work in which we showed that interleukin (IL)-13 blockade inhibited allergen-induced AHR, yet induction of pulmonary eosinophilia and OVA-specific IgE were unaffected (14) . Similarly, IgE-deficient and B cell-deficient mice develop AHR normally after allergen challenge (25, 26) . More important, all asthmatics do not have elevated serum IgE levels (27) . Unique genetic mechanisms appear to underlie asthmaassociated phenotypes in human populations. For example, QTL for serum IgE levels, but not AHR or eosinophils, have been identified on human chromosomes 8p23 (28), 11q13 (7, 29) , and 16 (7), whereas QTL for AHR, but not serum IgE or BAL eosinophils, map to human chromosomes 4 and 7 (7). In contrast, QTL for asthma-associated phenotypes occasionally share similar map locations. Most notably, chromosome 5q23-q33 contains QTL for AHR and elevated serum IgE (4, (30) (31) (32) .
Similarly, a controversy exists as to a causal role of eosinophils in the development of AHR. Although several studies support a role for IL-5 and eosinophils in the development of AHR in murine models, eosinophils and AHR have been dissociated in many examples. For example, Corry and coworkers (33) demonstrated that anti-IL-4 treatment of mice prevented AHR despite the presence of eosinophils in the lung. Furthermore, the development of AHR was not affected by an anti-IL-5 treatment that abrogated eosinophilia. In support of this dissociation between eosinophils and AHR, Zhang and associates (11) found a QTL on chromosome 10 that was specific for AHR alone; however, QTL for both tissue eosinophilia and AHR were colocalized on murine chromosome 11. Moreover, in the only study to date in which the map locations for AHR and eosinophils have been compared within a human population, both unlinked and linked map locations for these traits were found (4). Although these studies collectively suggest that characteristics of the asthmatic syndrome may be uniquely regulated, there is no dispute that they are often coordinately expressed in human disease. In summary, discordant linkages for AHR, serum IgE, and pulmonary eosinophils occur in humans and mice. Furthermore, while it appears that AHR may be dependent on the presence of eosinophils or IgE in some cases, it is clear that there are eosinophil-and IgE-independent mechanisms for AHR as well. These findings further support the notion that AHR can be generated via several pathways.
Our studies suggest that the genes controlling allergeninduced AHR are different from those controlling noninflammatory AHR. Specifically, we have previously shown that control of noninflammatory airway responsiveness in A/J and C3H/HeJ inbred strains linked to chromosome 6 (8). This linkage was subsequently confirmed by De Sanctis and colleagues in a study of the same strains (10). Our current finding of QTL for allergen-induced AHR on chromosome 2 in the same strains demonstrates that noninflammatory and allergen-induced AHR are uniquely regulated. Whereas De Sanctis and colleagues (9) found linkage for noninflammatory AHR in a different model (A/J and C57BL/6J mice) on chromosome 2 (peak lod between D2Mit397 and D2Mit266, cM position 69 to 109), this location was distinct from the region we identified containing two QTL for allergen-induced AHR (cM position 5 to 30). Additional support for independent control of noninflammatory and allergen-induced AHR is the fact that aller-gen-induced AHR in A/J mice was directly dependent on the presence of CD4 ϩ T cells (34) , whereas noninflammatory AHR was not (24) . These results suggest that allergen-induced AHR develops as a consequence of immunemediated processes and occurs by mechanisms that are unique from those controlling noninflammatory responsiveness.
Several methods have been developed to detect multiple QTL that are either linked or unlinked (19, 35, 36) ; however, the increase in power to detect QTL and to provide more precise position information for a QTL led us to initially use the composite interval mapping methods built into QTL Cartographer (37) . We report significant linkage for allergen-induced AHR on murine chromosome 2 in a mouse model. Composite interval analysis and permutation tests were employed to assess whether the two peaks on chromosome 2 better supported the presence of two distinct loci or just a single locus. The composite interval mapping results provided support for the two loci hypothesis as given in Figure 4 . Others have realized similar results in analyzing mouse crosses using composite interval mapping to resolve the number of QTL that may be present in a single broad peak in a likelihood plot for a single chromosome (38) . We believe the composite interval mapping technique was more informative in our case because of the potential interactions detected between the two loci. One of the strengths of the composite interval mapping method is that it can specifically model the genetic effect of multiple QTL and their interactions with other QTL instead of folding this useful information into a single experimental error term as is done in interval mapping methods. This serves to increase the statistical power to detect multiple linked or unlinked loci and to better resolve the position of the QTL. However, in applying the composite interval mapping method as implemented in QTL Cartographer, we found wide variation in the composite interval mapping results depending on: (1) the number of markers pulled in as cofactors; this number was varied by changing thresholds in the forward-backward stepwise regression, which varied the number of markers brought into the regression model; (2) the actual markers allowed to enter as cofactors; and (3) the size of the window used to block out markers tightly linked to the marker under consideration. The composite interval mapping lod score curve given in Figure 4 is representative of the curves generated from cofactor/window size combinations that gave strong support for the two loci hypothesis. However, other combinations were not as dramatic.
To further test the two loci hypothesis, we implemented the conditional empirical threshold test developed by Doerge and Churchill (19) . In our implementation of this test, we conditioned on the marker with the greatest marker-trait association, D2Mit416. We then performed the permutation test, as described in MATERIALS AND METHODS, on each marker on chromosome 2. Marker D2Mit298 yielded a result that approached statistical significance (P ϭ 0.06). However, this result was significant in that it further supported the two loci hypothesis because after controlling for the QTL effects explained by the conditioning marker, we were still able to detect an association between the trait and marker D2Mit298. Because our implementation of the permutation test only included conditioning on a single marker and then generating the permutations one marker at a time, we did not make optimal use of the information contained in flanking markers, something the composite interval mapping method is able to do. Therefore, it is reasonable to expect that the composite interval mapping method would give a more compelling result because the underlying model is able to incorporate more information than we were able to incorporate in a simple permutation test.
In addition to Abhr1 and Abhr2 on chromosome 2, we found suggestive evidence of a QTL for allergen-induced AHR on murine chromosome 7. The existence of multiple genes controlling this trait is also supported by a study by Zhang and colleagues (11) in which they found that allergen-induced AHR linked to chromosomes 10 and 11 in a cross between BP2 and BALB/cJ mice. The findings of unique linkages for allergen-induced AHR in two different murine models indicate that strain-specific QTL contribute to this phenotype and further support the notion that AHR can be generated via several pathways. Additional evidence supporting the contribution of several genes to allergen-induced AHR is our finding that the QTL identified in this study contribute only 23% of the total phenotype variance, a finding that is consistent with the contribution of QTL for AHR identified in other studies (8, 9, 11) . Thus, other genes together with environmental factors are likely to influence the pathways leading to allergen-induced AHR and are expected to have a significant impact on the expression of this trait.
The identification of strain-dependent QTL in animal models is consistent with the observation of multiple linkages to asthma-related traits in humans (4, 5, 7) . In fact, a substantial number of genetic loci have been shown to contribute to susceptibility to asthma and asthma-related phenotypes in different human cohorts (4, 5, 7) . Although some asthma susceptibility linkages are shared by different study populations, others appear to be unique to particular ethnic groups (5, 6) . Such diverse linkage results in human and animal studies suggest that genetic contributions to the development of AHR and asthma may result from alterations in a variety of different pathways or alterations in different genes within a single pathway. Because multiple stimuli can induce AHR and strain-or population-specific QTL underlie this phenotype, it is reasonable to propose that multiple genes may influence the expression of this trait.
Portions of the linkage regions identified in this study are syntenic to human chromosomal regions that have been linked with susceptibility to asthma or asthma-associated traits. Specifically, part of the region containing Abhr2 is homologous to human chromosome 9q (Table 1) , which has been linked to asthma susceptibility and elevated serum IgE levels in a human cohort (4) . In addition, the region defined by the suggestive QTL on murine chromosome 7 is homologous to human chromosome 19q13 ( Table 1) . Linkage of asthma-related phenotypes to 19q13 has been reported in two different ethnic groups (5, 6) . Although the genes underlying susceptibility to allergic asthma in our murine model may not necessarily predict specific genes underlying allergic asthma in humans, our studies are likely to be useful for identifying and confirming the pathways that produce asthma-related phenotypes.
Identification of the specific genes underlying QTL regulating allergen-induced AHR in the A/J backcross may be facilitated by our knowledge of the immunobiology of experimental allergic asthma. It is of interest, therefore, that the gene encoding GATA3 (Gata3) lies within the confidence interval surrounding Abhr1. GATA3 is a transcription factor, selectively expressed at high levels in T helper (Th)2 cells, that is both necessary and sufficient for Th2 cytokine gene expression in mice (39, 40) . Recent studies demonstrate that a dominant negative mutant of Gata3 inhibits allergen-induced inflammation in a murine model of asthma (41) . As we have demonstrated a strong association between susceptibility to allergen-induced AHR and Th2 cytokine production in our model, a polymorphism in this positional candidate gene could conceivably result in the polarized Th2 immune response seen in susceptible A/J mice (13, 14) . As the exact factors determining the propensity of asthmatic individuals to mount Th2 immune responses to inhaled antigens are unknown, these studies may shed light on pathways that govern responses in the lungs of susceptible individuals.
Other positional candidate genes near the Abhr1 locus include genes for the IL-1 receptor antagonist (Il1rn), mannose receptor (Mrc1), and IL-15 receptor alpha subunit (Il15ra). Positional candidate genes near Abhr2 include lipocalin (Lcn2), cathepsin B (Ctsb-rs), complement factor 5 (Hc), and prostaglandin synthase 1 (Ptgs1). Several positional candidate genes that map near the suggestive QTL on chromosome 7 may also affect airway function such as IL-11 and the gamma-aminobutyric acid (GABA) receptor genes Gabra5, Gabrb3, and Gabrg3. Many of the currently identified positional candidate genes are excellent candidates for contributing to allergen-induced AHR. Furthermore, additional positional candidate genes are likely to be identified as the murine and human synteny maps are completed.
In conclusion, we have identified two unique QTL on murine chromosome 2 for allergen-induced AHR in a murine model of asthma and report suggestive evidence of an additional QTL for this trait on chromosome 7. Studies are currently underway to determine the contribution of individual genes lying within these linkage regions. The identification of genes regulating allergen-induced AHR in this model will provide high quality candidate genes for analysis in human asthma cohorts.
